Lattice Biologics upgrades to OTCQB Venture Market
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Lattice Biologics Inc. got approval to upgrade its common shares to the OTCQB Venture Market from the Pink Open Market, effective Jan. 31.
Company shares on the OTCQB will trade under the ticker symbol LBLTF.
